Results 121 to 130 of about 123,714 (295)
Implementation of guidelines for intravenous iron therapy in heart failure patients
Abstract Aims We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital. Methods and results Patients with left ventricular ejection fraction (LVEF) < 50% and New York Heart Association (NYHA) class II–IV who visited ...
Milou Gamage+5 more
wiley +1 more source
Abstract Aims We aim to assess the efficacy of congestion relief and safety associated with adding SGLT2i (viz., dapagliflozin 10 mg) to intravenous loop diuretics within 24 h of hospital presentation in patients with acute heart failure (AHF). Methods and results A single‐centre open‐label clinical research study enrolled 98 patients admitted with an ...
Daniela Mocan+7 more
wiley +1 more source
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg+17 more
wiley +1 more source
The fate of isologous, homologous and heterologous ferritin molecules in the rat [PDF]
Seong S. Han, Ihn Han, Arthur G. Johnson
openalex +1 more source
Clinical evidence in transcatheter edge‐to‐edge valve repair. EF, ejection fraction; eGFR, estimated glomerular filtration rate; EROA, effective regurgitant orifice area; GDMT, guideline‐directed medical therapy; HF, heart failure; HHF, hospitalization for heart failure; LVEDV, left ventricular end‐diastolic volume; MR, mitral regurgitation; MVARC ...
Gianluigi Savarese+13 more
wiley +1 more source
Ultrastructural visualization ofKlebsiellacapsules by polycationic ferritin [PDF]
R. Weiß, Hans-Gerd Schiefer, H. Krauß
openalex +1 more source
Differences in baseline characteristics between major trials of intravenous (IV) iron therapy in heart failure. LVEF, left ventricular ejection fraction; SGLT2, sodium–glucose cotransporter 2. Aims Prior randomized trials have reported conflicting evidence regarding the efficacy of intravenous (IV) iron in patients with heart failure with reduced ...
Stefan D. Anker+44 more
wiley +1 more source
Mechanism of Plasma Iron Incorporation into Hepatic Ferritin
Abraham Mazur, Saul Green, Anne Carleton
openalex +1 more source
Micropinocytosis of transferrin by developing red cells: an electron- microscopic study utilizing ferritin-conjugated transferrin and ferritin-conjugated antibodies to transferrin [PDF]
Andrew Sullivan, JA Grasso, LR Weintraub
openalex +1 more source
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura+23 more
wiley +1 more source